missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ DX3-213B
Description
DX3-213B is a potent oxidative phosphorylation (OXPHOS) complex I (also known as NDUFS7) antagonist (IC50 = 3.6 nM). DX3-213B impairs ATP generation (IC50 = 11 nM) and inhibits the proliferation of MIA PaCa-2 cells (IC50 = 9 nM) in galactose-containing media. In vivo, DX3-213B significantly delays tumor growth in a syngeneic mouse model of pancreatic cancer. DX3-213B is orally bioavailable.
Specifications
Specifications
| Chemical Name or Material | (4,4-Difluoro-1-piperidinyl)[(3R)-1-[[4-[(1-methylethyl)sulfonyl]phenyl]sulfonyl]-3-piperidinyl]methanone |
| CAS | 2749555-66-4 |
| Quantity | 10 mg |
| Product Line | Tocris |
| Target | Oxidative Phosphorylation Inhibitors |
| Molecular Formula | C20H28F2N2O5S2 |
| Purity | 0.97 |